Assess whether the carve-out is operable on day one (f623ce)

SITUATION Buy-side QoE lead in a health-system acquiring a specialty practice has one working extract — revenue-quality bridge from bookings to cash — after a contractor who actually wrote the core code. If revenue-quality bridge from bookings to cash cannot support the carve-out is operable, the only defensible M&A Due Diligence output is hold.

DECISION Buy-side QoE lead in a health-system acquiring a specialty practice must choose Proceed / Reprice / Walk / Hold using revenue-quality bridge from bookings to cash after a contractor who actually wrote the core code.

HYPOTHESES TO TEST 1. The population in revenue-quality bridge from bookings to cash is the one a contractor who actually wrote the core code named, so Proceed follows for this Legal, IP, and Regulatory file. 2. The population in revenue-quality bridge from bookings to cash is adjacent only to a contractor who actually wrote the core code; Reprice is the honest M&A Due Diligence call. 3. A health-system acquiring a specialty practice already contained a contractor who actually wrote the core code before revenue-quality bridge from bookings to cash arrived; no new Legal, IP, and Regulatory path. 4. Provenance on revenue-quality bridge from bookings to cash after a contractor who actually wrote the core code is broken; do not pick Proceed or Reprice yet.

ANALYSIS REQUIRED 1. Separate a one-off add-back from a recurring earnings issue in revenue-quality bridge from bookings to cash. 2. Map reps, earnout mechanics, and integration risk a health-system acquiring a specialty practice would inherit. 3. Tie quality-of-earnings, working-capital, and contingent items in revenue-quality bridge from bookings to cash to the carve-out is operable. 4. For this M&A Due Diligence Legal, IP, and Regulatory file, read revenue-quality bridge from bookings to cash against a contractor who actually wrote the core code and write the one fact that would move the carve-out is operable for buy-side QoE lead.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Legal, IP, and Regulatory packet (revenue-quality bridge from bookings to cash after a contractor who actually wrote the core code). The follow-on Legal, IP, and Regulatory action is what buy-side QoE lead does next: implement the option, assign an owner, and log the missing fact.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on the carve-out is operable, then the evidence in revenue-quality bridge from bookings to cash, then the action for buy-side QoE lead - Hypothesis scorecard against revenue-quality bridge from bookings to cash: supported / rejected / untestable - Named option among Proceed, Reprice, Walk and the fact that kills the others - Owner and next date for buy-side QoE lead in a health-system acquiring a specialty practice